Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Medicines and Healthcare products Regulatory Agency

MHRA issues drug alert after drugs mislabelled

Pharmacists have been warned to be aware of possible wrong labelling on a number of batches of drugs including medicines to treat epilepsy, anxiety and depression.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for a number of products produced by Focus Pharmaceuticals warning that an error with barcodes has been discovered on some batches.

It said that when the barcodes are scanned, they may not identify the product. The other product details printed on the carton, including the name, strength and pharmaceutical form of the medicine are correct.

The drugs affected include pregabalin oral solution, trazodone capsules, nortriptyline tablets, nefopam hydrochloride tablets, and dicycloverine tablets and oral solution.

The MHRA has asked any pharmacy that holds this stock to remove it from robotic or automated dispensing systems, and carry out manual dispensing using the written labelling instead.

The MHRA said that there was no risk to the quality of the product from the incorrect barcoding, so the affected batches are not being recalled by the manufacturer.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203523

Readers' comments (1)

  • You'd have thought that the amount that Focus (i.e. Corncordia) charge for their generic medicines (as opposed to when they were branded medicines), they'd be able to have some sort of check in place to ensure this basic sort of thing is correct...!

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • MHRA head office

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.